actinomycin
n
activ
partli
induct
phosphoryl
death
cell
induc
n
morpholog
resembl
inflammationinduc
pyroptosi
cell
destruct
trigger
activ
treatment
n
camptothecin
strongli
upregul
two
activ
howev
activ
detect
cell
may
prime
pyroptosi
absenc
crucial
trigger
investig
addit
innat
immun
element
reveal
n
camptothecin
stimul
express
sting
stimul
interferon
gene
two
antivir
protein
code
gene
led
us
investig
regul
sting
mode
upregul
sting
attenu
knockdown
cell
upsurg
examin
gene
activ
inhibit
inhibitor
pkr
kinas
pkr
test
due
abil
phosphoryl
surprisingli
activ
even
pkr
knockdown
cell
abil
prevent
activ
express
innat
immun
gene
may
sourc
strong
antiinflammatori
action
moreov
cell
expos
n
influenc
neighbor
cell
paracrin
fashion
instanc
shed
ectodomain
protein
induc
mode
express
gene
activ
also
spur
express
inhibitor
interferon
trigger
signal
conclud
stimul
prime
cell
product
interferon
upregul
sting
may
activ
negativefeedback
within
signal
system
enhanc
product
actinomycin
n
synergist
activ
pathway
variou
cell
line
actinomycin
anticanc
drug
low
concentr
inhibit
rna
polymeras
rna
pol
rna
pol
inhibit
induc
nucleolar
stress
shown
trigger
phosphoryl
although
mechan
action
unclear
prevent
interact
neg
regul
lead
increas
steadi
state
level
occurr
may
help
actinomycin
dactiv
kinas
phosphoryl
conspicu
sign
treatment
synergi
seen
increas
phosphoryl
serin
increas
mrna
level
gene
phosphoryl
difficult
observ
presenc
actinomycin
undetect
presenc
howev
substanc
appli
togeth
statu
reach
high
level
phosphoryl
consid
marker
activ
effici
stimul
express
proapoptot
gene
lung
cancer
cell
line
phosphoryl
upon
treatment
n
also
observ
camptothecin
cpt
treatment
anticanc
drug
inhibit
topoisomeras
strong
induc
apoptosi
cpt
induc
death
cell
via
characterist
apoptosi
mechan
includ
morpholog
dna
content
activ
caspas
altern
cell
death
induc
n
treatment
morpholog
resembl
necrosi
show
characterist
swell
burst
cell
balloon
cytoplasm
without
extens
cell
bleb
characterist
apoptosi
sever
form
regul
cell
death
rcd
includ
apoptosi
character
apoptot
morpholog
anoth
mode
rcd
character
necrot
morpholog
refer
pyroptosi
pyroptosi
trigger
convers
inact
procaspas
activ
cleav
gasdermin
protein
cleavag
turn
form
pore
cell
membran
lead
permeabil
cell
balloon
death
activ
trigger
destruct
cell
also
cleav
biolog
activ
signal
molecul
strong
mediat
inflamm
major
pyrogen
promot
influx
activ
neutrophil
well
activ
tcell
bcell
promot
releas
nkcell
tcell
base
previous
report
observ
recent
work
investig
hypothes
activ
n
cotreat
induc
pyroptosi
cell
start
studi
test
hypothesi
lung
adenocarcinoma
american
type
cultur
collect
atcc
os
osteosarcoma
atcc
cell
grown
previous
describ
stock
solut
chemic
prepar
dmso
actinomycin
sigmaaldrich
st
loui
mi
usa
camptothecin
mm
calbiochemmerck
darmstadt
germani
mm
selleck
chemic
llc
houston
tx
usa
imidazolooxindol
pkr
inhibitor
mm
sigmaaldrich
stock
solut
nigericin
sodium
salt
mm
tocri
bioscienc
minneapoli
mn
usa
prepar
ethanol
stock
solut
dilut
cultur
medium
follow
concentr
nm
actinomycin
nigericin
camptothecin
dilut
concentr
indic
result
section
control
cell
mocktreat
medium
contain
dmso
human
carrier
stock
solut
purchas
cell
signal
technolog
danver
final
concentr
indic
result
section
control
knockdown
cell
prepar
previous
describ
util
lentivirusdeliv
shrna
molecul
control
pkr
knockdown
cell
prepar
lentivirusdeliv
shrna
molecul
use
transductionreadi
lentivir
particl
pkr
control
santa
cruz
biotechnolog
accord
manufactur
protocol
due
fact
cell
posit
transduc
puromycinresist
select
clone
necessari
cultur
medium
cell
expos
n
mocktreat
control
concentr
centrifug
rcf
vivaspin
turbo
mwco
concentr
sartorium
stedim
lab
stonehous
uk
centrifug
medium
time
requir
concentr
ml
subsequ
load
buffer
ad
concentr
medium
mixtur
incub
min
chill
ice
store
thirti
five
microlit
taken
western
blot
apoptot
cell
analyz
use
pe
annexin
v
apoptosi
detect
kit
bd
bioscienc
san
jose
ca
usa
accord
manufactur
protocol
use
bd
facscanto
ii
cytomet
total
rna
sampl
isol
cell
use
rneasi
mini
kit
qiagen
hilden
germani
cdna
synthes
mulv
revers
transcriptas
random
hexam
appli
biosystem
foster
citi
ca
usa
measur
mrna
level
perform
use
realtim
pcr
master
mix
sybr
biotechnolog
gdynia
poland
follow
oligonucleotid
use
primer
ctt
tct
gct
ctt
cca
ca
aca
tca
cag
gaa
cag
gc
cag
aag
ccc
aga
ctt
ac
ggg
tcc
act
tca
agc
ac
atg
cgt
gcc
cta
ctc
tc
cct
cac
tca
tga
ctg
cc
gca
gat
tct
ctt
ctc
cgt
c
gca
cat
tga
agc
tca
ggt
c
tca
agg
tgg
ttc
cac
ga
atg
ggg
aag
agc
tcg
aa
sting
atc
gga
tat
ctg
cgg
ct
ggc
agt
tta
tcc
agg
aa
ttc
tgt
agg
atg
gta
gca
c
gag
gaa
ggt
tct
ggc
gaa
gcc
caa
cca
aca
aa
gga
tgc
agc
taa
agt
tcg
primer
intern
refer
gene
agc
agg
agt
atg
acg
ag
ata
aag
cca
tgc
caa
tc
biotez
amplif
perform
realtim
system
biorad
hercul
ca
usa
pcr
run
cdna
sampl
amplifi
triplic
rel
quantit
mrna
carri
use
method
refer
mean
standard
deviat
calcul
three
biolog
replic
wholecel
lysat
prepar
use
ip
buffer
supplement
proteas
phosphatas
inhibitor
describ
previous
aliquot
lysat
separ
sdspage
gel
electrotransf
onto
pvdf
membran
incub
primari
antibodi
membran
incub
h
room
temperatur
block
solut
skim
milk
pb
follow
primari
antibodi
obtain
cell
signal
technolog
rabbit
polyclon
antibodi
antist
antipkr
anticleav
antipycard
alia
tyr
rabbit
polyclon
rabbit
polyclon
antibodi
antibodi
antibodi
abcam
cambridg
uk
antibodi
clone
emd
millipor
temecula
ca
usa
anti
alia
sheep
polyclon
antibodi
r
system
minneapoli
mn
usa
load
control
antibodi
obtain
santa
cruz
biotechnolog
incub
primari
antibodi
perform
overnight
block
solut
hrpconjug
secondari
antibodi
antimous
antirabbit
antisheep
detect
chemiluminesc
supersign
west
pico
supersign
west
femto
chemiluminesc
substrat
thermo
fisher
scientif
necessari
band
western
blot
least
three
independ
experi
quantit
use
genetool
softwar
syngen
cambridg
uk
student
ttest
use
calcul
statist
signific
differ
regulatori
element
clone
report
vector
encod
firefli
luciferas
promega
madison
wi
usa
human
altern
promot
amplifi
pcr
genom
dna
sampl
cell
use
primer
gagctc
acc
ttc
tct
gtg
tcc
aga
cc
aagctt
ccc
cat
ggg
tac
gac
aac
primer
design
contain
restrict
site
underlin
saci
hindiii
respect
amplifi
dna
ligat
saci
hindiii
site
human
promot
amplifi
pcr
genom
dna
sampl
cell
use
primer
gagctc
aga
tct
tgc
cac
tgc
act
cc
ctcgag
ctc
cca
ggt
ttc
ttc
aga
c
primer
design
contain
restrict
site
underlin
saci
xhoi
respect
amplifi
dna
ligat
saci
xhoi
site
pcr
perform
pfuplu
dna
polymeras
mix
eurx
poland
ensur
high
fidel
dna
amplif
insert
dna
sequenc
ensur
clone
contain
mutat
mutat
cwwg
w
sequenc
put
respons
element
promot
creat
use
geneart
sitedirect
mutagenesi
plu
kit
life
technolog
carlsbad
ca
usa
forward
tcagacaacagaggagcgtccc
acggcatgactc
complementari
revers
gagtcatgccg
tgggacgctcctctgttgtctga
primer
forward
gagtccttgtccaaggcgtccgtgggttgaagcc
revers
ggcttcaacccacggacgccttggacaaggactc
primer
site
mutat
underlin
luciferas
report
assay
perform
describ
recent
short
os
cell
cotransfect
use
promega
combin
report
vector
encod
firefli
luciferas
control
regulatori
element
wild
type
mutant
express
vector
encod
wildtyp
encod
mutant
gift
dr
bert
vogelstein
dr
kenneth
w
kinzler
john
hopkin
univers
baltimor
md
usa
neg
control
plasmid
replac
empti
vector
transfect
mixtur
also
contain
prltk
encod
renilla
sp
luciferas
control
hsvtk
promot
intern
control
next
day
cell
wash
cultur
medium
incub
fresh
medium
addit
h
cell
lyse
plb
buffer
dual
luciferas
report
assay
system
promega
activ
luciferas
measur
firefli
luciferas
activ
normal
renilla
sp
luciferas
activ
transfect
perform
triplic
three
independ
experi
earlier
studi
demonstr
treatment
modal
employ
us
induc
cell
cycl
arrest
phase
n
cell
cycl
arrest
apoptosi
cpt
moreov
cell
expos
n
observ
molecular
sign
autophagi
name
convers
protein
cytosol
lipid
membranebound
form
start
studi
better
character
fate
cell
expos
cpt
n
western
blot
confirm
stronger
induct
apoptosi
determin
activ
execution
fig
cell
treat
cpt
compar
treatment
modal
cleavag
indic
intrins
extrins
signal
appar
autocrin
fashion
play
role
induct
apoptosi
cpt
result
confirm
cytometr
analysi
earli
apoptot
cell
frequent
detect
cell
expos
cpt
fig
cell
expos
n
observ
slight
increas
percentag
necrot
cell
consist
morpholog
observ
publish
previous
timecours
experi
cell
treat
either
cpt
n
assess
abil
substanc
induc
express
procaspas
observ
strong
accumul
protein
follow
treatment
cpt
n
fig
express
degre
activ
determin
conjunct
activ
determin
assess
amount
total
amount
serin
phosphoryl
variou
kinas
togeth
phosphoryl
residu
promot
stabil
inhibit
nuclear
export
review
serin
phosphoryl
sever
kinas
promot
format
activ
arrang
molecul
tetram
bind
dna
regul
express
target
gene
protein
code
marker
activ
pathway
treatment
modal
induc
express
howev
appear
late
synchron
strong
accumul
observ
consist
data
publish
gupta
et
al
demonstr
gene
regul
howev
coincid
accumul
phosphoryl
suggest
strongli
activ
effici
stimul
gene
transcript
semiquantit
rtpcr
confirm
gene
stimul
transcript
level
demonstr
strong
synergi
actinomycin
lead
upregul
fig
actinomycin
act
alon
upregul
mrna
approxim
respect
work
togeth
treatment
stimul
express
increas
camptothecin
act
alon
also
caus
strong
stimul
mrna
although
slightli
weaker
n
western
blot
show
consist
rtpcr
actinomycin
synergist
stimul
protein
express
synergi
also
strong
induct
phosphoryl
fig
thu
data
suggest
n
cpt
treatment
prime
cell
pyroptosi
start
produc
execution
caspas
requir
form
cell
death
pyroptot
cell
death
start
activ
selfcleavag
small
larg
subunit
subsequ
form
tetram
two
two
molecul
subunit
detect
antibodi
use
fig
wherea
subunit
detect
anoth
antibodi
fig
neither
antibodi
detect
conspicu
activ
caspas
despit
strong
express
uncleav
procaspas
form
kda
fig
b
thu
despit
strong
accumul
upon
treatment
n
cpt
signal
activ
execution
caspas
appar
miss
cleavag
procaspas
trigger
recruit
multiprotein
structur
known
inflammasom
crucial
element
within
inflammasom
pattern
recognit
receptor
prr
detect
pathogenassoci
molecular
pattern
pamp
damageassoci
molecular
pattern
damp
least
three
major
type
inflammasom
activ
bacteri
molecul
mechan
irrit
inflammasom
stimul
cytosol
doublestrand
dna
dsdna
dna
molecul
usual
origin
genom
virus
eg
ebv
damag
chromosom
cytosol
dsdna
recogn
two
inflammasom
protein
interferon
gamma
induc
protein
indirectli
activ
adaptor
protein
pycard
two
activ
isoform
kda
pycard
bind
via
pyrin
domain
bind
procaspas
via
card
domain
review
interestingli
gene
shown
gene
henc
explor
possibl
molecul
form
least
one
inflammasom
type
express
cell
upon
treatment
n
cpt
result
shown
fig
expectedli
detect
major
upregul
follow
strong
activ
case
actinomycin
stimul
express
synergist
manner
moreov
notic
aforement
adapt
protein
pycard
express
rel
constant
level
fig
smallest
isoform
pycard
kda
inhibitor
activ
repress
upon
exposur
actinomycin
n
cpt
fig
thu
three
protein
abl
form
least
one
inflammasom
procaspas
pycard
express
cell
expos
n
cpt
absenc
conspicu
activ
may
result
lack
least
one
crucial
stimul
signal
howev
cell
appear
prime
undergo
pyroptosi
knowledg
pyroptosi
activ
come
studi
macrophag
cell
line
deriv
leukemia
eg
cell
induct
pyroptosi
cell
deriv
carcinoma
poorli
explor
commonli
use
protocol
induct
pyroptosi
macrophag
involv
pretreat
cell
lipopolysaccharid
induc
express
inflammasom
element
subsequ
treatment
bacteri
toxin
nigericin
lower
cytosil
potassium
level
requir
inflammasom
assembl
cell
treat
n
contain
element
least
one
inflammasom
type
pycard
decid
find
lower
cytosol
potassium
level
nigericin
induc
caspas
activ
cell
first
expos
n
h
control
cell
mocktreat
subsequ
wash
cell
control
experiment
either
mocktreat
expos
min
nigericin
fig
cell
harvest
trypsin
protein
lysat
prepar
describ
materi
method
blot
expos
antibodi
recogn
endogen
level
caspas
upon
cleavag
thu
antibodi
recogn
activ
cleav
subunit
caspas
subsequ
blot
reprob
antibodi
recogn
differ
epitop
within
subunit
caspas
antibodi
use
experi
present
fig
western
blot
shown
fig
consist
data
present
fig
induc
cell
treat
n
activ
observ
band
detect
unexpectedli
antibodi
rais
caspas
cleav
detect
protein
band
cell
expos
n
nigericin
howev
band
locat
kda
marker
way
expect
size
kda
moreov
larger
expect
protein
band
one
kda
one
kda
also
detect
second
antibodi
cell
expos
n
nigericin
fig
thu
two
differ
antibodi
rais
differ
epitop
within
subunit
caspas
recogn
larger
expect
protein
speci
cell
pretreat
n
expos
nigericin
consist
extens
posttransl
modif
caspas
reduc
mobil
protein
electrophoresi
howev
without
extens
detail
analys
firm
conclus
drawn
short
experi
show
evid
classic
activ
caspas
cell
pretreat
n
expos
nigericin
protein
activ
also
may
part
signal
system
stimul
express
antivir
protein
exampl
togeth
anoth
cytosol
dsdna
bind
molecul
cga
cyclic
gmpamp
synthas
cooper
activ
sting
protein
stimul
interferon
gene
activ
kinas
turn
phosphoryl
activ
transcript
factor
bind
respons
element
mani
antivir
gene
stimul
transcript
eg
gene
code
respect
gene
code
innat
immun
protein
regul
addit
aforement
stimul
transcript
among
other
thu
hypothes
activ
n
cpt
could
stimul
gene
code
protein
innat
immun
far
identifi
gene
gene
protein
regul
decid
explor
sting
protein
locat
signal
pathway
also
synergist
induc
actinomycin
cpt
western
blot
analysi
show
inde
case
fig
moreov
accumul
sting
associ
phosphoryl
indic
strong
activ
need
effici
stimul
sting
express
encourag
result
extend
search
innat
immun
gene
select
gene
code
variou
element
defens
system
bacteri
viral
pathogen
one
guid
select
avail
trust
commerci
antibodi
select
protein
moreov
focus
gene
put
bind
site
identifi
tebaldi
et
al
interferoninduc
protein
tetratricopeptid
repeat
antivir
effector
protein
bind
viral
mrna
molecul
outcompet
cellular
translat
initi
factor
inhibit
product
viral
protein
form
function
complex
relat
protein
interferoninduc
protein
tetratricopeptid
repeat
stabil
protein
express
promot
bind
viral
mrna
enhanc
activ
translat
inhibitor
moreov
serv
adapt
molecul
help
activ
aforement
kinas
upstream
regul
mav
protein
pattern
recognit
receptor
unlik
prr
particip
format
inflammasom
rather
local
mitochondria
studi
function
give
contradictori
result
investig
suggest
induc
product
reactiv
oxygen
speci
ro
other
demonstr
dampen
oxid
stress
import
poorli
understood
element
innat
immun
compon
first
identifi
inflammasom
pattern
recognit
receptor
activ
variou
bacteri
toxin
includ
bacillu
anthraci
lethal
toxin
analysi
gene
express
also
select
pkr
kinas
code
gene
antivir
effector
function
particip
activ
phosphoryl
result
extend
analysi
present
fig
express
sting
correl
level
upregul
activ
use
studi
wherea
primarili
upregul
n
fig
data
togeth
result
semiquantit
rtpcr
fig
indic
strong
synergi
actinomycin
activ
sting
gene
gene
activ
substanc
addit
synergi
actinomycin
induc
express
level
load
control
cell
treat
n
cpt
indic
time
con
mocktreat
control
b
chang
level
mrna
measur
semiquantit
realtim
pcr
rna
sampl
isol
mocktreat
cell
con
cell
incub
h
actinomycin
actd
nut
substanc
n
cpt
mrna
level
mocktreat
popul
defin
result
repres
mean
standard
deviat
three
biolog
replic
p
twotail
student
ttest
treatment
versu
control
c
level
wholecel
lysat
protein
phosphoryl
load
control
cell
treat
h
locat
molecular
weight
marker
indic
fashion
wherea
express
pkr
chang
detect
thu
conclud
sting
gene
could
activ
princip
respons
sever
stress
factor
knockdown
shrna
molecul
deliv
cell
lentivirus
prevent
strong
accumul
phosphoryl
turn
prevent
upregul
protein
code
known
gene
fig
show
experiment
model
indic
gene
regul
fashion
use
model
found
knockdown
attenu
upregul
sting
protein
cell
expos
n
fig
line
upregul
mrna
also
attenu
cell
fig
surprisingli
time
point
knockdown
influenc
express
neither
fig
b
howev
perform
timecours
experi
wildtyp
knockdown
cell
found
earlier
timepoint
treatment
n
h
express
lower
knockdown
cell
fig
moreov
timecours
experi
demonstr
express
sting
attenu
cell
knockdown
throughout
pyrin
domain
western
blot
protein
lysat
cell
con
mocktreat
nig
expos
nigericin
min
n
expos
actinomycin
h
min
fresh
medium
n
nig
expos
actinomycin
h
subsequ
nigericin
min
blot
probe
anticleav
rabbit
monoclon
antibodi
cell
signal
technolog
cst
blot
left
probe
antibodi
cst
treatment
period
strengthen
conclus
three
gene
regul
fashion
experi
perform
camptothecin
stress
factor
yield
similar
result
present
supplementari
fig
knockdown
attenu
upregul
protein
fig
line
upregul
mrna
also
attenu
cell
fig
addit
knockdown
associ
attenu
upregul
sting
mrna
rtpcr
western
blot
data
demonstr
sting
gene
regul
manner
sting
gene
contain
put
respons
element
basepair
downstream
transcript
start
site
thu
locat
outsid
promot
region
henc
stage
exclud
character
contain
least
two
plausibl
identifi
tebaldi
et
al
one
locat
far
downstream
transcript
start
site
bp
wherea
locat
upstream
start
major
transcript
approxim
bp
interestingli
site
locat
within
promot
altern
transcript
clone
altern
promot
luciferas
report
vector
dna
fragment
contain
put
defin
threequartersit
one
quarter
element
bind
one
molecul
activ
tetram
miss
canon
consist
two
decamer
halfsit
rrrcwwgyyi
r
purin
pyrimidin
w
arrang
tandemli
decam
turn
consist
two
pentamer
quarter
site
rrrcw
arrang
headtohead
site
still
abl
bind
tetram
provid
molecul
properli
modifi
post
translat
fig
quartersit
direct
present
arrow
roman
numer
put
altern
promot
quarter
site
number
ii
miss
spite
wildtyp
express
vector
significantli
elev
luciferas
activ
control
promot
fig
b
critic
element
quartersit
iii
iv
mutat
indic
fig
mutant
promot
activ
fig
moreov
mutant
lost
sequencespecif
bind
dna
longer
abl
activ
wildtyp
promot
fig
interestingli
fragment
clone
promot
mark
fig
open
rectangl
contain
chipseq
peak
bind
site
identifi
sequenc
chromatin
immunoprecipit
antibodi
presenc
peak
locat
chromosom
posit
genom
version
report
metaanalysi
perform
nguyen
et
al
chipseq
peak
identifi
other
region
public
avail
chipatla
tool
visual
supplementari
fig
thu
test
combin
chipseq
data
indic
dna
fragment
clone
contain
genuin
control
express
henc
appear
regul
direct
bind
promot
tebaldi
et
al
identifi
put
approxim
bp
upstream
transcript
start
site
deviat
consensu
three
posit
denot
fig
smallcas
letter
importantli
put
contain
two
cwwg
element
consensu
mutat
one
consensu
element
shown
fig
unexpectedli
mutat
slightli
attenu
abil
activ
promot
fig
thu
dna
sequenc
may
contribut
abil
promot
respond
like
anoth
bind
site
play
major
role
within
promot
critic
mutant
abl
activ
promot
thu
clone
dna
sequenc
gene
respond
wildtyp
locat
major
known
aforement
metaanalysi
locat
chipseq
peak
may
shed
light
mechan
bind
promot
contain
chipseq
peak
locat
posit
chromosom
genom
version
mark
open
rectangl
fig
visual
supplementari
fig
sequenc
overlap
dna
fragment
found
form
structur
see
nguyen
et
al
ref
therein
altern
dna
conform
form
singlestrand
guaninerich
region
fold
stabl
fourstrand
helic
structur
vicin
chipseq
peak
examin
evid
bind
structur
element
control
express
nearbi
gene
data
gener
hypothesi
may
control
express
element
identifi
promot
region
definit
warrant
investig
activ
n
cpt
associ
strong
upregul
innat
immun
gene
sting
order
find
kinas
might
respons
activ
condit
took
candidateprotein
approach
mani
kinas
directli
indirectli
activ
pamp
one
kinas
pkr
detect
presenc
viral
doublestrand
rna
cellular
rna
molecul
appear
stress
phosphoryl
translat
initi
factor
result
inhibit
synthesi
viral
protein
cell
control
knockdown
mocktreat
con
expos
actinomycin
n
h
b
control
knockeddown
cell
treat
n
examin
western
blot
con
cell
mocktreat
c
express
mrna
indic
protein
determin
semiquantit
rtpcr
mocktreat
control
cell
con
cell
expos
n
h
cell
knockeddown
mark
wherea
control
knockdown
consh
result
repres
mean
standard
deviat
three
biolog
replic
p
valu
calcul
twotail
student
ttest
ns
non
signific
product
viru
progeni
moreov
pkr
phosphoryl
henc
decid
test
hypothesi
pkr
involv
activ
experiment
condit
pkr
inhibit
imidazolooxindol
compound
name
consid
specif
inhibitor
cell
treat
cpt
n
addit
concentr
fig
slightli
reduc
phosphoryl
wherea
almost
complet
block
phosphoryl
residu
accompani
strong
inhibit
n
blockag
cpt
accumul
protein
encod
wellstudi
gene
fig
surprisingli
impact
phosphoryl
trigger
actinomycin
act
alon
fig
treatment
reduc
phosphoryl
indic
specif
influenc
phosphoryl
select
amino
acid
thu
inhibit
enzym
induc
phosphoryl
order
find
pkr
enzym
respons
activ
upon
treatment
n
cpt
prepar
pkr
knockdown
cell
shown
fig
knockdown
success
cell
bare
detect
express
pkr
activ
chang
fig
moreov
abl
strongli
inhibit
phosphoryl
even
cell
pkr
express
consider
reduc
fig
thu
conclud
model
phosphoryl
pkrindepend
fashion
howev
clearli
block
phosphoryl
also
upregul
sting
induc
n
fig
camptothecin
fig
consist
hypothesi
respons
upregul
gene
activ
appar
pkrindepend
occur
pkrposit
well
pkr
knockdown
cell
fig
fig
thu
data
show
activ
upon
cpt
n
fig
promot
contain
respons
element
arrow
roman
numer
mark
quartersit
nucleotid
match
consensu
quartersit
mark
smallcas
letter
locat
chipseq
peak
report
other
mark
open
rectangl
promot
fragment
form
quadruplex
ref
therein
mark
black
rectangl
b
c
fold
chang
normal
firefli
luciferas
activ
nfla
os
cell
transfect
express
vector
report
vector
code
firefli
luciferas
transcript
control
promot
clone
gene
present
panel
mut
prefix
indic
promot
version
mutat
site
indic
panel
e
fold
chang
nfla
cotransfect
wildtyp
promot
report
plasmid
express
vector
code
either
wildtyp
mutant
mean
standard
deviat
three
biolog
replic
perform
triplic
present
p
p
twotail
student
ttest
treatment
unidentifi
kinas
sensit
inhibit
moreov
kinas
respons
activ
examin
innat
immun
gene
strengthen
conclus
perform
similar
experi
use
inhibitor
parent
unmodifi
cell
line
os
cell
line
deriv
osteosarcoma
fig
b
c
experi
yield
similar
conclus
compound
attenu
phosphoryl
prevent
attenu
upregul
innat
immun
gene
sting
welldefin
gene
code
thu
kinas
phosphoryl
stimul
innat
immun
gene
least
two
differ
cell
line
suggest
widespread
phenomenon
principl
accumul
gene
could
result
autocrin
stimul
cell
interferon
secret
respons
stress
condit
associ
exposur
n
cpt
order
test
hypothesi
monitor
activ
statu
transcript
factor
phosphoryl
cell
expos
type
eg
type
ii
interferon
posit
control
treat
cell
human
h
expect
induc
accumul
well
accumul
protein
code
interferonstimul
gene
fig
moreov
treatment
also
led
accumul
pkr
protein
code
gene
known
activ
interferon
howev
phosphoryl
accumul
cell
expos
cpt
n
suggest
interferon
signal
transcript
factor
induc
experiment
condit
interferon
respons
upregul
examin
innat
immun
gene
two
gene
strongli
stimul
n
decid
examin
whether
treatment
modal
act
addit
synergist
treat
cell
demonstr
fig
figur
show
n
treatment
synergist
stimul
express
synergi
present
quantit
fig
upregul
n
appear
addit
expectedli
stimul
phosphoryl
n
howev
unexpectedli
n
attenu
phosphoryl
induc
camptothecin
similar
attenu
effect
interferoninduc
phosphoryl
fig
conclud
n
camptothecin
may
activ
mechan
prevent
strong
phosphoryl
interferontr
cell
phosphoryl
kinas
enzym
inhibit
protein
prevent
excess
stimul
immun
system
hypothes
observ
attenu
phosphoryl
associ
increas
level
two
phosphoryl
form
express
code
target
cell
expos
h
either
n
cpt
alon
combin
indic
concentr
b
western
blot
show
express
phosphoryl
form
cell
expos
h
actinomycin
actd
actinomycin
n
camptothecin
cpt
cell
also
expos
use
concentr
fig
treatment
inhibit
activ
pathway
pkr
kinaseindepend
fashion
express
phosphoryl
form
cell
knockeddown
express
pkr
control
knockdown
expos
n
cpt
h
b
express
indic
protein
cell
knockeddown
express
pkr
control
knockdown
expos
n
andor
h
express
cell
treat
n
camptothecin
western
blot
show
case
fig
observ
suggest
may
gene
use
experiment
approach
employ
gene
studi
demonstr
strong
activ
camptothecin
n
stimul
express
mrna
fig
protein
fig
level
actinomycin
stimul
express
synergist
fashion
fig
b
show
knockdown
attenu
upregul
fig
e
indic
regul
fashion
moment
evid
gene
regul
directli
metaanalysi
ngueyn
et
al
show
three
chipseq
peak
within
promot
contain
sequenc
motif
thu
strongli
activ
may
potenti
prevent
excess
stimul
immun
system
noteworthi
antibodi
use
experi
recogn
kda
protein
whose
express
chang
treatment
condit
stark
contrast
rtpcr
data
expect
molecular
mass
kda
use
sensit
detect
system
antibodi
recogn
also
protein
approxim
kda
express
pattern
similar
express
mrna
fig
b
henc
conclud
kda
band
blot
repres
kda
molecul
offtarget
protein
last
question
want
answer
concern
abil
ntreat
cell
modifi
environ
detail
character
secretom
cell
subject
anoth
studi
want
show
exampl
increas
secret
extracellular
protein
induc
treatment
n
select
protein
gene
directli
regul
took
advantag
fact
unusu
collagen
molecul
fulllength
form
anchor
cellular
membran
kda
molecul
extracellular
domain
kda
ectodomain
shed
cell
environ
increas
shed
correl
decreas
cell
motil
expos
cell
n
complet
medium
h
subsequ
cell
rins
pb
expos
n
serum
freemedium
h
control
cell
mocktreat
remov
serum
reduc
expect
background
stain
serum
protein
end
experi
number
control
cell
expos
cell
similar
whole
cell
lysat
prepar
attach
cell
medium
centrifug
g
min
remov
detach
cell
subsequ
ml
medium
concentr
use
vivaspin
turbo
concentr
protein
lysat
equal
volum
concentr
media
analyz
western
blot
fig
expectedli
detect
strong
induct
protein
cell
expos
n
cell
lysat
collagen
form
fig
upregul
innat
immun
associ
gene
n
camptothecin
block
treatment
os
cell
line
os
b
cell
expos
n
n
h
control
cell
mocktreat
con
c
similar
experi
perform
use
camptothecin
cpt
stress
factor
cell
expos
h
indic
protein
modifi
form
subsequ
detect
western
blot
kda
kda
detect
plausibl
cleavag
fulllength
molecul
occur
alreadi
vesicl
transport
collagen
cell
surfac
howev
cultur
medium
kda
ectodomain
detect
fulllength
form
visibl
even
strong
overexposur
film
ectodomain
medium
origin
cell
lysi
would
also
expect
detect
fulllength
molecul
medium
thu
conclud
ectodomain
leak
passiv
die
cell
henc
infer
cell
expos
n
strongli
induc
ectodomain
shed
cell
modifi
environ
find
n
treatment
induc
gene
code
immunerel
extracellular
molecul
search
chipseq
peak
gene
encod
variou
cytokin
chemokin
interestingli
use
chipatla
found
chipseq
peak
exon
border
gene
fig
chipseq
peak
detect
cell
express
engin
molecul
strong
cooper
bind
monom
found
actinomycin
strongli
synerg
induct
fig
moreov
induct
n
cpt
significantli
attenu
knockdown
cell
fig
thu
strongli
activ
abil
induc
express
chang
activ
nearbi
immun
cell
nonredund
growth
factor
mani
hematopoiet
cell
lineag
especi
nk
cell
start
studi
analysi
express
activ
statu
cell
strongli
activ
code
consider
upregul
cpt
n
howev
observ
proteolyt
activ
despit
cpt
n
stimul
express
gene
code
inflammosom
compon
requir
autoproteolyt
activ
thu
appear
robust
stimul
prime
cell
undergo
death
call
pyroptosi
howev
bulk
cell
die
fashion
experiment
condit
fact
cell
expos
cpt
n
express
compon
inflammasom
activ
differ
damp
respond
bacteri
toxin
respond
foreign
dsdna
speak
favor
prime
hypothesi
seem
cell
vagu
experi
stress
condit
determin
die
base
ultim
specif
trigger
express
gene
exampl
extrem
synergi
actinomycin
stimul
express
gene
fig
use
knockdown
cell
confirm
observ
gupta
et
al
schlereth
et
al
upregul
fashion
fig
howev
must
properli
posttransl
modifi
order
stimul
express
phosphoryl
appear
among
key
modif
fig
modif
like
also
requir
interestingli
schlereth
et
al
fig
upregul
innat
immun
associ
gene
n
camptothecin
involv
activ
cell
mocktreat
con
expos
either
n
camptothecin
cpt
h
cell
expos
recombin
human
ngml
h
subsequ
express
indic
protein
examin
western
blot
one
antibodi
detect
activ
transcript
factor
phosphoryl
tyrosin
b
cell
expos
n
cpt
ifn
ngml
treatment
modal
simultan
express
total
phosphoryl
examin
western
blot
c
quantit
western
blot
analysi
cell
expos
indic
mean
standard
deviat
calcul
western
blot
protein
lysat
prepar
three
biolog
replic
undetect
control
cell
express
set
cell
expos
n
found
activ
gene
critic
depend
cooper
molecul
form
dnabind
tetram
mutat
specif
destroy
cooper
molecul
significantli
influenc
abil
tetram
activ
cell
cycl
inhibitor
eg
howev
mutat
complet
destroy
abil
activ
henc
suspect
cpt
n
strongli
stimul
promot
posttransl
modif
may
favor
cooper
bind
monom
question
aris
physiolog
condit
result
activ
degre
allow
gene
stimul
level
activ
achiev
camptothecin
possibl
anticanc
drug
deriv
camptothecin
topotecan
irinotecan
wide
use
clinic
henc
possibl
camptothecinrel
drug
facilit
pyroptosi
howev
condit
beyond
treatment
anticanc
drug
abl
strongli
stimul
vivo
suspect
condit
occur
local
within
tissu
associ
infect
variou
pathogen
initi
induc
local
tissu
damag
secret
variou
toxin
trigger
activ
immun
cell
turn
releas
plethora
locallyact
toxic
factor
includ
dnadamag
ro
biolog
actinomycin
antibiot
toxic
also
eukaryot
cell
produc
streptomyc
antibioticu
gramposit
bacterium
live
soil
possibl
strong
activ
result
similar
toxin
produc
bacteria
abl
infect
human
soil
bacteria
streptomyc
genu
found
produc
infect
immunodefici
individu
human
live
tropic
region
context
conjectur
surpris
strong
activ
associ
induct
mani
immun
gene
detect
studi
found
n
cpt
treatment
stimul
express
sting
gene
code
protein
involv
innat
immun
identifi
far
gene
cell
knockeddown
express
upregul
sting
attenu
indic
four
gene
regul
fashion
activ
gene
indic
modifi
microenviron
cell
send
signal
help
prolifer
surviv
nearbi
immun
cell
case
abl
show
gene
promot
activ
ectop
express
moreov
identifi
within
promot
use
sitedirect
mutagenesi
accord
publish
metaanalys
highthroughput
studi
fig
gene
express
upregul
manner
measur
rel
mrna
level
cell
expos
indic
substanc
combin
treatment
h
cpt
camptothecin
con
mocktreat
control
actd
actinomycin
n
nut
p
p
student
ttest
b
protein
express
cell
expos
indic
substanc
combin
h
c
rel
mrna
level
knockdown
cell
control
cell
consh
expos
n
cpt
c
hour
result
repres
mean
standard
deviat
three
independ
experi
p
valu
calcul
student
ttest
e
express
indic
protein
knockdown
cell
control
cell
expos
cpt
n
h
notic
sting
regul
fashion
cell
line
treatment
condit
howev
accord
criteria
use
author
metaanalys
gene
target
appar
discrep
may
result
fact
origin
studi
use
stress
factor
activ
enough
stimul
express
gene
henc
probabl
fell
certain
threshold
metaanalysi
consid
direct
target
case
unexpectedli
found
knockdown
lentivirusdeliv
shrna
particl
strongli
attenu
express
especi
mrna
level
confus
base
degre
upregul
gene
express
appear
close
correl
degre
activ
determin
presenc
phosphoryl
moreov
kinas
inhibitor
prevent
activ
also
prevent
induct
howev
data
hand
safer
conclud
regul
open
issu
need
clarifi
gene
new
addit
list
gene
code
innat
immun
protein
addit
aforement
requir
optim
upregul
code
protein
direct
antivir
activ
regul
code
transcript
regul
stimul
express
interferon
inflammatori
cytokin
form
complex
activ
stimul
express
mani
antivir
effector
molecul
also
regul
thu
facilit
product
interferon
henc
surpris
mani
virus
even
one
associ
cancer
eg
sar
coronaviru
produc
protein
inactiv
strikingli
discov
form
tight
complex
viral
protein
context
find
strongli
activ
induc
express
sting
pivot
point
anoth
mechan
use
stimul
synthesi
antivir
cytokin
sting
locat
crossroad
two
signal
pathway
one
pathway
emerg
detect
dna
virus
cga
protein
second
fig
exposur
n
upregul
express
gene
code
secret
protein
express
protein
kda
wholelength
molecul
kda
ectodomain
cell
lysat
concentr
medium
cell
expos
h
n
h
complet
medium
h
serumfre
medium
b
genom
browser
igv
view
bind
peak
border
gene
use
chipatla
tool
import
public
avail
coverag
track
four
chipseq
experi
aim
find
bind
site
cell
line
expos
ioniz
radiat
nutlin
sampl
id
cell
line
ectop
express
wildtyp
sampl
id
ectop
express
pair
engin
molecul
strong
cooper
bind
monom
sampl
id
cell
treat
nutlin
sampl
id
c
measur
rel
mrna
level
cell
expos
indic
substanc
combin
treatment
h
rel
mrna
level
knockdown
cell
control
cell
consh
expos
n
cpt
h
p
valu
three
repeat
calcul
student
ttest
origin
detect
rna
virus
rigi
receptor
converg
activ
transcript
factor
directli
stimul
transcript
gene
type
interferon
found
spite
strong
upregul
sting
interferon
produc
model
infer
lack
phosphoryl
cell
expos
cpt
n
probabl
cell
prime
interferon
product
lack
specif
trigger
eg
infect
viru
actual
activ
transcript
interferon
gene
hypothesi
pkr
respons
activ
lead
induct
innat
immun
gene
support
observ
although
activ
induct
innat
immun
gene
block
specif
inhibitor
pkr
near
complet
knockdown
pkr
prevent
activ
upregul
innat
immun
gene
moreov
abl
block
activ
upregul
innat
immun
gene
even
cell
almost
full
knockdown
pkr
probabl
anoth
exampl
offtarget
activ
kinas
inhibitor
whatev
target
kinas
block
compound
play
major
role
activ
respons
cpt
n
treatment
even
submicromolar
concentr
inhibit
phosphoryl
moreov
block
phosphoryl
argu
gener
block
mani
kinas
know
block
activ
kinas
directli
phosphoryl
block
activ
kinas
phosphoryl
amino
acid
form
signal
kinas
modifi
studi
demonstr
protect
tissu
damag
inflamm
especi
central
nervou
system
light
observ
inhibit
activ
fact
strong
induc
cell
death
must
consid
cytoprotect
activ
compound
mediat
inhibit
apoptosi
inflamm
offtarget
activ
alreadi
notic
investig
opinion
search
kinas
inhibit
great
import
may
play
major
role
stimul
apoptosi
innat
immun
surpris
find
studi
activ
express
n
cpt
manner
protein
inhibit
signal
pathway
stimul
variou
cytokin
includ
type
eg
type
ii
interferon
henc
appear
anoth
gene
innat
immun
system
regul
contrast
gene
mention
discuss
inhibit
interferoninduc
signal
may
seem
counterintuit
opinion
plausibl
suspect
relationship
part
neg
feedback
loop
within
immun
signal
system
good
analog
relationship
signal
system
loop
activ
gene
code
neg
regul
hypothes
task
quickli
silenc
signal
stress
factor
disappear
also
possibl
prevent
excess
stimul
innat
immun
activ
strong
stress
factor
cell
addit
expos
interferon
unusu
situat
lung
epithelium
instanc
found
other
upregul
specif
activ
acut
myeloid
leukemia
cell
also
support
notion
gene
thu
data
present
paper
observ
made
other
support
notion
innat
immun
stressrespons
system
strongli
influenc
moreov
upregul
antivir
gene
cpt
n
anoth
observ
grow
bodi
evid
anticanc
chemotherapeut
agent
strong
antivir
properti
result
upregul
innat
immun
gene
properti
anticanc
drug
must
care
consid
plan
anticanc
strategi
combin
use
oncolyt
virotherapi
chemotherapeut
agent
strong
activ
actinomycin
act
camptothecin
associ
upregul
mani
innat
immun
gene
consid
function
protein
conclud
strongli
stimul
prime
cell
pyroptosi
induct
interferon
gene
activ
sting
ie
downregul
attenu
express
regul
innat
immun
play
doubl
role
induc
gene
eg
sting
help
trigger
interferon
product
induc
prevent
excess
stimul
interferon
signal
experiment
condit
activ
upregul
innat
immun
protein
strongli
inhibit
antiinflammatori
substanc
consid
specif
inhibitor
pkr
kinas
act
model
appar
pkrindepend
manner
thu
unidentifi
kinas
inhibit
play
major
role
activ
stimul
subset
innat
immun
gene
supplementari
data
articl
found
onlin
http
work
support
grant
mr
agk
nation
scienc
centr
ncn
poland
author
declar
conflict
interest
